H. Lundbeck A/S (HLBBF)
OTCMKTS · Delayed Price · Currency is USD
5.52
0.00 (0.00%)
At close: Aug 12, 2025
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of $5.84 billion as of August 26, 2025. Its market cap has decreased by -2.19% in one year.
Market Cap
5.84B
Enterprise Value
7.56B
Revenue
3.70B
Ranking
n/a
PE Ratio
10.64
Stock Price
$5.52
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 4.54B to 5.84B, an increase of 28.70%. That is a compound annual growth rate of 8.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 5.85B | 6.64% |
| Dec 30, 2024 | 5.49B | 16.62% |
| Dec 29, 2023 | 4.70B | 28.73% |
| Dec 30, 2022 | 3.65B | -19.48% |
| Jun 10, 2022 | 4.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |